Northrop Grumman CorporationBeat earnings, raised guidance, record backlog, and analyst price target implies 21.7% undervaluation.

Northrop Grumman reported better-than-expected quarterly earnings and revenue, lifted its full-year sales guidance, and highlighted a record backlog following substantial contract awards across key defense programs. The stock has fallen about 10% year to date, with a recent close near $525, while a consensus analyst price target of $670.48 suggests a 21.7% undervaluation. The most bullish target stands at $815 and the most bearish at $533. Longer-term returns remain strong, with three-year and five-year total shareholder returns of 20.77% and 58.16%, respectively. Risks include dependence on large U.S. defense programs and potential cost overruns on fixed-price contracts.
Northrop Grumman CorporationBeat earnings, raised guidance, record backlog, and analyst price target implies 21.7% undervaluation.